MAKE CANCER A BENIGN EXPERIENCE Trademark

Trademark Overview


On Monday, May 10, 2021, a trademark application was filed for MAKE CANCER A BENIGN EXPERIENCE with the United States Patent and Trademark Office. The USPTO has given the MAKE CANCER A BENIGN EXPERIENCE trademark a serial number of 90701065. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Earli Inc.. The MAKE CANCER A BENIGN EXPERIENCE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer

Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical labo...
make cancer a benign experience

General Information


Serial Number90701065
Word MarkMAKE CANCER A BENIGN EXPERIENCE
Filing DateMonday, May 10, 2021
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7287794
Registration DateTuesday, January 23, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Goods and ServicesProducts for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
Goods and ServicesMedical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code005
First Use Anywhere DateWednesday, January 4, 2023
First Use In Commerce DateTuesday, January 24, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code044
First Use Anywhere DateWednesday, October 5, 2022
First Use In Commerce DateWednesday, October 5, 2022

Trademark Owner History


Party NameEarli Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameEarli Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameEarli Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2023ASSIGNED TO LIE
Friday, July 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 10, 2023NON-FINAL ACTION E-MAILED
Monday, April 10, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, February 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 1, 2023USE AMENDMENT FILED
Thursday, February 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 1, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 10, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, May 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, May 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 23, 2022NON-FINAL ACTION WRITTEN
Thursday, January 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 13, 2022NON-FINAL ACTION E-MAILED
Thursday, January 13, 2022NON-FINAL ACTION WRITTEN
Thursday, January 13, 2022ASSIGNED TO EXAMINER
Tuesday, August 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 13, 2021NEW APPLICATION ENTERED